Seon Ye Kim

Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer

Dong Ha Kim, HyeongRyul Kim, Yun Jung Choi et al. · Experimental & Molecular Medicine · 2019 · 385 citations · Full text

Medicine, Immunology, Oncology +17

MET and AXL Inhibitor NPS-1034 Exerts Efficacy against Lung Cancer Cells Resistant to EGFR Kinase Inhibitors Because of MET or AXL Activation

Jin Kyung Rho, Yun Jung Choi, Seon Ye Kim et al. · Cancer Research · 2013 · 144 citations

Medicine, Oncology, Pharmacology +16

Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4

Dong Ha Kim, Sojung Park, HyeongRyul Kim et al. · Cancer Letters · 2020 · 106 citations

Medicine, Molecular Biology, Oncology +12

Enhanced Glycolysis Supports Cell Survival in EGFR-Mutant Lung Adenocarcinoma by Inhibiting Autophagy-Mediated EGFR Degradation

Ji Hye Kim, Boas Nam, Yun Jung Choi et al. · Cancer Research · 2018 · 72 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer

Ji Hyun Park, Yun Jung Choi, Seon Ye Kim et al. · Oncotarget · 2016 · 70 citations · Full text

Medicine, Oncology, Pharmacology +17